International Stem Cell (ISCO) Non Operating Interest Expenses (2010 - 2026)

International Stem Cell (ISCO) has reported Non Operating Interest Expenses for 17 consecutive years, with $34000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 10.53% year-over-year to $34000.0 in Q2 2026; TTM through Jun 2026 was $144000.0, a 5.88% decrease from a year earlier, with the FY2025 full-year figure at $151000.0, up 4.14% from the prior year.
• Non Operating Interest Expenses was $34000.0 for Q2 2026 at International Stem Cell, down from $35000.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $41000.0 in Q1 2025 and troughed at $33000.0 in Q2 2022.
• A 5-year average of $35529.4 and a median of $35000.0 in 2022 frame the typical range for Non Operating Interest Expenses.
• The widest YoY moves for Non Operating Interest Expenses: up 94.44% in 2022, down 19.51% in 2022.
• Over 5 years, Non Operating Interest Expenses stood at $33000.0 in 2022, then increased by 3.03% to $34000.0 in 2023, then gained by 14.71% to $39000.0 in 2024, then retreated by 10.26% to $35000.0 in 2025, then decreased by 2.86% to $34000.0 in 2026.
• The last three Non Operating Interest Expenses figures came in at $34000.0 (Q2 2026), $35000.0 (Q4 2025), and $37000.0 (Q3 2025), per Business Quant data.